Actively Recruiting
Group Telehealth Behavioral Cough Suppression Therapy Pilot Study
Led by University of Montana · Updated on 2024-11-27
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effectiveness of behavioral cough suppression therapy (BCST) delivered in a group telehealth setting for adults with refractory chronic cough (RCC). RCC is defined as a cough lasting at least 8 weeks that has not improved with standard medical treatment. The study aims to see if BCST, a treatment provided by specialty-trained speech-language pathologists (SLPs), can be effectively delivered remotely to improve accessibility, especially for patients in rural areas with limited access to trained SLPs. Participants will receive BCST in a group format via telehealth, conducted by specialty-trained SLPs. The therapy focuses on managing and suppressing chronic cough behaviorally. The study includes 4 to 6 treatment sessions, held once per week. There are no placebo or comparator groups, as the study evaluates this intervention delivered remotely. The study is classified as an early phase 1 trial. During the study, participants will complete assessments including the Leicester Cough Questionnaire at baseline, one week after treatment, and one month post-treatment. They will also rate their cough severity using the Patient Global Impression of Severity Scale during each treatment session and at one month after treatment. Participants will be monitored for changes in cough severity and treatment impact over time. The total participation duration spans the treatment period plus follow-up assessments up to one month after treatment ends.
CONDITIONS
Brief Title
Group Telehealth Behavioral Cough Suppression Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years old
- Dry cough lasting at least 8 weeks
- Evaluated and treated by at least one physician for cough
- Chest X-ray or chest CT scan related to cough with normal results
- Access to a computer or tablet with a camera and able to use it independently
- Reliable internet access
- Willing to maintain confidentiality of personal information related to others in the study
You will not qualify if you...
- Under age 18
- Coughing up blood
- Current smoker of any substance
- History of smoking for 10 or more years
- Diagnosed with chronic lung conditions such as COPD, emphysema, lung cancer, idiopathic pulmonary fibrosis, chronic bronchitis, or asthma (unless asthma diagnosis is unconfirmed and treatments have not helped cough)
- Current or past diagnosis of head and neck cancer
- Complaints of swallowing difficulty
- Taking medications known to cause cough including certain ACE inhibitors
- Prior behavioral cough suppression therapy with a speech-language pathologist or respiratory therapist
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 4 to 6 weeks
Participants receive behavioral cough suppression therapy delivered in a group setting via telehealth.
Weekly group telehealth sessions (4 to 6 sessions)
Duration - 1 month
Participants complete assessments one week and one month after treatment to evaluate cough severity and quality of life.
2 remote follow-up visits
Trial Site Locations
Total: 1 location
1
University of Montana
Missoula, Montana, United States, 59812
Actively Recruiting
Research Team
J
Jane E Reynolds, PhD
L
Laurie J Slovarp, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here